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The plexin family of transmembrane receptors are
important for axon guidance, angiogenesis, but also
in cancer. Recently, plexin-B1 somaticmissensemu-
tationswere found inbothprimary tumorsandmetas-
tases of breast and prostate cancers, with several
mutations mapping to the Rho GTPase binding do-
main (RBD) in the cytoplasmic region of the receptor.
Here we present the NMR solution structure of this
domain, confirming that theprotein hasboth aubiqui-
tin-like fold and surface features. Oncogenic muta-
tions T1795AandT1802A are located in a loop region,
perturb the average structure locally, and have no
effect on Rho GTPase binding affinity. Mutations
L1815F and L1815P are located at the Rho GTPase
binding site and are associated with a complete
loss of binding for Rac1 and Rnd1. Both are found
to disturb the conformation of the b3-b4 sheet and
the orientation of surrounding side chains. Our study
suggests that the oncogenic behavior of the mutants
can be rationalized with reference to the structure of
the RBD of plexin-B1.
INTRODUCTION
The plexin family of single-pass transmembrane proteins is com-
prised of high-affinity receptors for guidance molecules of the
semaphorin family of ligands (Nakamura et al., 2000). Plexins
were first cloned from neuronal tissues (Maestrini et al., 1996;
Ohta et al., 1995) and were shown to play important roles in
the repulsion of axonal growth cones (Negishi et al., 2005; Patel
and Van Vactor, 2002; Artigiani et al., 1999), typically leading to
growth cone collapse and axonal repulsion. Recently it has
been demonstrated that plexins are also involved in cardiovas-
cular development and angiogenesis (Basile et al., 2004, 2006;
Gitler et al., 2004; Serini et al., 2003; Torres-Vazquez et al.,
2004; Toyofuku et al., 2004), invasive growth of epithelial cells246 Structure 16, 246–258, February 2008 ª2008 Elsevier Ltd All ri(Giordano et al., 2002), T cell-dentritic cell interaction in immune
system (Wong et al., 2003), as well as in skeletal development
(Gomez et al., 2005; Takegahara et al., 2006).
By contrast to other transmembrane receptors, plexins medi-
ate semaphorin signaling by direct interactions with several small
GTPases: Rac1, Rnd1, RhoD, and R-Ras. Furthermore, plexin-
B1 is also a binding partner, if not activator for GTPase regulatory
proteins, including the PDZ-RhoGEF and the LARG exchange
factor for RhoA found in leukemia patients (Aurandt et al., 2002;
Driessens et al., 2002; Hirotani et al., 2002; Perrot et al., 2002;
Swiercz et al., 2002), as well as for p190RhoGAP (Barberis
et al., 2005), which downregulates RhoA. As part of the normal
signaling mechanism, stimulation of Plexin-B1 by its ligand
Sema4D activates a GAP function toward R-Ras, which in turn
antagonizes integrin-based cell adhesion (Oinuma et al., 2006).
This latter signal is known to play an important role in cancer pro-
gression. These observations, together with the role of plexins in
the regulation of cell motility, have associated the receptors with
processes in cancer metastasis (Basile et al., 2006; Giordano
et al., 2002). Furthermore, it is thought that, in oncogenic cell
transformation, there is considerable cross and recursive signal-
ing between pathways involving small GTPases. Thus, a detailed
structural characterization of the domains of plexin that bind di-
rectly to small GTPases will provide considerable insight into
the role of plexins in cancer.
Recently, several plexin-B1 somatic missense mutations were
identified in prostate as well as in breast cancer cells (Williamson
andMasters, 2004;Wonget al., 2007). Single nucleotide changes
at 13 positions in plexin-B1 DNA were found in 41 primary pros-
tate cancer tumors of 89 patients that were analyzed. Mutations
were also found in 8 of 9 prostate cancer bonemetastases and in
7 of 17 lymph node metastases. In addition, 6 of 30 metastatic
breast cancer patients also showed mutations in plexin-B1
(Williamson and Masters, 2004). Among the mutations, several
amino acid changes map to the cytoplasmic region of residues
1742–1862 of human plexin-B1 that is responsible for Rho
GTPase binding (Rho GTPase binding domain [RBD]). Specifi-
cally, mutation T1795A was found in 43% of primary prostate
tumor samples and in an additional 58% of the metastatic sam-
ples.Mutation L1815Pwas also found in several primary prostateghts reserved
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The Plexin-B1 Rho GTPase Binding Domaintumors, while L1815F was identified in several breast cancer tis-
sue samples (Williamson andMasters, 2004; M.Williamson, per-
sonal communication). Other less frequent mutations include
T1802A. Because they occur in the central RBD, there is consid-
erable interest in understanding the effect of these mutations on
plexin’s structure and, therefore, function.
Studies of the RBD of plexin-B1 in our laboratory suggested
awell-structured, independent folding unit with a weak sequence
and secondary structural homology to ubiquitin (Tong and Buck,
2005). The wild-type plexin-B1 RBD exists as a weak dimer in so-
lution, and we have shown that a single site mutation, W1830F,
disrupts the dimerization while retaining the structure and Rac1/
Rnd1/RhoD binding activity of the domain (Tong et al., 2005).
Here, we present the NMR solution structure of this monomeric
protein and results of molecular dynamics (MD) simulations to
model the oncogenic mutations. We evaluated the structural fea-
tures of these proteins by NMR spectroscopy and thermody-
namic measurements with the aim of rationalizing the effect of
the oncogenic mutations in the context of the RBD.
RESULTS
The Plexin-B1 RBD Has a Ubiquitin Fold
with the Insertion of Long Loops
Distance restraints from NOE experiments, dihedral restraints
from TALOS, and directly detected hydrogen bond restraints
were used for structure calculation of plexin-B1 RBD (Table 1).
The backbone trace of monomeric plexin-B1 RBD W1830F is
shown in Figure 1A as an ensemble of the 20 structures with
lowest energy from 200 structures calculated with Cyana (Gun-
tert, 2004) and refined in explicit solvent with XPLOR-NIH (Linge
et al., 2003). Residues near to the N terminus (prior to 1746) and
at the C terminus (beyond 1853) are not well converged in the
structure due to the lack of restraints. The chain is outside the
fold of the domain. The long loops L2 and L4 are also not well
converged, which is consistent with considerable protein inter-
nal flexibility as measured by NMR relaxation (Bouguet-Bonnet
and Buck, 2008). The ribbon representation of the average
structure (Figure 1B) shows five b strands (b1, 1749–1753; b2,
1767–1771; b3, 1804–1808; b4, 1815–1817; b5, 1845–1850), an
a-helix (a1, 1777–1786), and a helical turn (a2, 1836–1839). The
20 structures have good geometry and high consistency with
the restraints—98.7% of the residues are in most favored or in
the additionally allowed regions of Ramachandran space (Las-
kowski et al., 1996). The average backbone root-mean-square
deviation (rmsd) of the secondary structure units is 0.28 A˚.
Previously, we reported the unexpected sequence homology
and secondary structural similarity between the plexin RBD and
ubiquitin (Tong and Buck, 2005). The 3D solution structure de-
rived here confirms this finding: a comparison using DALI (Holm
and Park, 2000) gives a Z-score of 7.4 (significant similarity) be-
tween plexin RBD and ubiquitin (PDB code: 1UBQ). The rmsd of
Ca atoms between the secondary structure units—containing
cores of the two proteins—is 2.2 A˚ (Figure 1C).
Hydrogen Bonding Network in Plexin-B1 RBD
An HNCO-type NMR experiment (Cordier and Grzesiek, 1999;
Kovacs et al., 2005) allowed the direct observation of a total of
18 hydrogen bonds, defining both acceptors and donors unam-Structure 16,biguously. In the structure calculations supplemented by these
restraints, a total of 37 hydrogen bonds exist in at least 8 struc-
tures out of the final ensemble of 20 conformers. Shown in
Figure 2A are the topology of the plexin RBD structure and the
medium- and long-range hydrogen bonding patterns. Strands
b1/b2 and b3/b4/b5 form typical antiparallel b sheets, while
b1/b5 strands in the center of the sheet are parallel. Importantly,
in addition to long-range hydrogen bonds and NOEs, the NMR
experiment showed main chain-main chain and side chain-
main chain hydrogen bonding between Q1837 and D1773, as
well as between I1777 and N1834, which constrain a short turn
between b2 and a1 to the end of helical turn a2. Similar tertiary
structure hydrogen bonds are also observed in ubiquitin, giving
this part of the fold increased definition. The N-terminal part of
the loop between b1 and b2 is proximate to b5, brought close
by a hydrogen bond between L1849 and A1756. It is interesting
to note that, by contrast to ubiquitin, there are fewer hydrogen
bonds between the parallel strands, b1 and b5, located in the
center of the plexin domain. This is consistent with the observa-
tion that these central b strands are each one residue shorter
Table 1. Statistics for the 20 Lowest Energy Plexin-B1 RBD
W1830F Structures
Statistic Value
Number of restraints
Total distance restraints 1877
Intraresidue (i, i)a 405
Sequential (i, i + 1) 610
Medium range (1 < ji  jj < 5) 347
Long Range (ji  jjR 5) 515
Total dihedral angle restraints 116
Phi 58
Psi 58
Structure statistics (20 structures)
Rmsds from the mean structureb (A˚)
Backbone atoms 1.32 ± 0.30
Heavy atoms 1.78 ± 0.26
Rmsds from the mean structure
for secondary structure unitsc
Backbone atoms 0.28 ± 0.05
Heavy atoms 0.79 ± 0.18
Ramachandran statistics (%)
ProcheckNMR
Most favored 78.3
Additional allowed 20.4
Generously allowed 0.9
Disallowed 0.5
Constraint violations
NOE distances(A˚) 0.017 ± 0.0012
Bonds (A) 0.017 ± 0.002
Angles () 1.3 ± 0.23
a i, j represent residue number.
b Y1746–L1853.
c Limits of secondary structure units are calculated by MolMol:
1749–1753,1767–1771,1777–1786,1804–1807,1815–1817,1836–1839,
1845–1850.246–258, February 2008 ª2008 Elsevier Ltd All rights reserved 247
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The Plexin-B1 Rho GTPase Binding Domainthan in ubiquitin, and the arrangement is likely to endow the
protein fold with reduced stability (see below).
The patterns of sequence conservation within the plexin
and ubiquitin family are compared in Figure 3, as is the dis-
tribution of surface nonpolar and charged regions in Figure 4.
Common features, but also some differences are seen in the
latter analysis. Results from both analyses are discussed
below.
Figure 1. Structure of the Plexin-B1 RBD
(A) Backbone trace of 20 structures of plexin-B1 RBD W1830F with the lowest energy.
(B) Ribbon representation of the average RBD structure with elements of secondary structure labeled.
(C) Superposition of the Ca trace of the average structure of the plexin-B1 RBD W1830F (PBD: 2JPH, red) and of human ubiquitin (PDB code: 1UBQ, green).
Figure 2. Topology and Hydrogen Bond Pattern in the Plexin-B1 RBD Structure
(A) Cartoon representation of the topology of plexin-B1 RBD structure and hydrogen bonding pattern. Side chains of residues N1834 and Q1837, and amide or
carbonyl groups of A1756, D1773, I1777 and S1818, are shown in ball-sticks.
(B) Cartoon representation of the topology of ubiquitin structure and hydrogen bonding pattern. aHelices are colored in orange, b strands in blue, and 3,10 helices
in pink. Protons are shown in gray, carbons in black, nitrogens in blue, and oxygens in red. Hydrogen bonds are labeled with orange dashed arrows. Direction of
arrow head indicates donor to acceptor connection, thus a double-headed arrow implies hydrogen bonding from both the amide proton of residue A to the
carbonyl oxygen of residue B and the amide proton of residue B to the carbonyl oxygen of residue A.
248 Structure 16, 246–258, February 2008 ª2008 Elsevier Ltd All rights reserved
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As the RBD is the central part of a signal transduction protein,
and the oncogenic mutations are known to perturb the function
of the receptor (Wong et al., 2007), we investigated the GTPase
binding affinity, the thermodynamic stability, as well as the struc-
ture of four oncogenic mutants.
Figure 5 shows the location of the mutation sites in relation to
the common binding region for active Rac1 and Rnd1 that has
recently been identified by NMR surfacemapping and cross-sat-
uration experiments (Tong et al., 2007). L1815P and L1815F are
at the binding interface, and it is, therefore, not unexpected that
the mutations will have a significant effect on binding.
Isothermal titration calorimetry (ITC) was used to determine
the binding affinity of the proteins with constitutively active
Rac1.Q61L. The two mutants, T1795A and T1802A, bind to
Rac1 with an affinity similar to that of the wild-type plexin-B1.
The interaction is exothermic with an unfavorable entropy similar
to wild-type plexin or monomeric plexin-B1 W1830F. The free
energy of binding is also unchanged for T1795A and T1802Amu-
tants (7.1 kcal/mol) (Table 2). By contrast, neither the L1815P
nor L1815F mutants detectably bind to Rac1 (or Rnd1 [data not
shown]), as demonstrated by GST pull-down assay and ITC
(Figure 6), showing that both mutations dramatically disrupt the
interaction of the plexin-B1 RBD with these Rho GTPases.
Global Structure and Thermodynamic Stability
of the RBD and of the Mutants
The far UV circular dichroism (CD) spectra of the wild-type and
four mutant proteins, T1795A, T1802A, L1815F, and L1815P,
are super-imposable, showing that there is no major change in
Figure 3. Residue Conservation in the
Plexin Family for the RBD Region
Conserved residues by ConSurf (Armon et al.,
2001) indicated on the RBD main chain (A) and
protein surface (B). Proteins on the right are back
views of the left images by rotating 180 around
an x axis, horizontal on the page.
their secondary structural content. The
overall stability of the RBD is rather mod-
est, with a free energy (DG) of approxi-
mately 3.5 kcal/mol at 15C, and it is
possible that the mutations affect the
overall stability of the domain. The pro-
teins were titrated with denaturant
GdnHCl and the free energy of unfolding,
DG, and m values were derived from the
CD data at 222 nm (Table 3).
It is found that three of the oncogenic
mutants are slightly more stable than the
wild-type and monomeric RBD variant,
W1830F. Mutation of Thr to Ala may
enhance the stability of the RBD, with an
overall decrease of the solvent-accessi-
ble surface of the proteins. This could
also be the case for the Leu to Phe muta-
tion at residue 1815. In order to examine
this issue more closely, we considered
m values, which is a parameter derived from the fitting of the
denaturation profile and which has been found to be empirically
related to the amount of surface area change that occurs upon
protein folding (Myers et al., 1995). Unfolding of T1795A and
L1815F is accompanied by a slight increase in m values. This is
consistent with the idea that, in the context of a protein, the Ala
and Phe side chains present more buried surface area relative
to the wild-type residues. The Leu to Pro mutation at residue
1815 occurs on b strand 4, and significantly destabilizes the pro-
tein by removing up to two hydrogen bonds (Figure 2B and see
below). We also determined the transition temperature from
folded tounfolded structure (Tm) for all four cancermutants bydif-
ferential scanning calorimetry. T1795A and T1802A have similar
Tm values (52C) compared to wild-type or the monomeric
RBD, whereas L1815P shows lower Tm (43
C) (Table 2).
Structural Changes Detected by NMR Chemical Shift
Perturbation and Molecular Modeling
Structural changes in the mutants with respect to monomeric
plexin-B1 W1830F are detected as considerably perturbed,
and significantly perturbed when chemical shifts (Dd > 0.25 ppm
and > 0.35 ppm, respectively) were observed in 1H-15N HSQC
NMR spectra. This information is shown relative to the location
of the mutations in Figures 7A–7D and as a function of sequence
in Figures S1A and S1B in the Supplemental Data available with
this article online.
For mutant L1815F (Figure 7A) and mutant L1815P (Figure 7B)
located in b strand 4, several chemical shift perturbations (Dd >
0.25 ppm) are seen for amides close to the site of the substitution
in the tertiary fold (b strand 3, a-2, and for part of the long
Structure 16, 246–258, February 2008 ª2008 Elsevier Ltd All rights reserved 249
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The Plexin-B1 Rho GTPase Binding Domainloop L3). However, in both cases, amides more distant from this
region also experience perturbations, such as D1799, L1849,
and T1795 in the case of L1815P, and R1801 in the case of
L1815F. This suggests that conformational and/or protein
dynamics changes are also propagated to more distant regions,
such as long loop L2 and b strand 5.
Figure 4. Surface Charge of the Plexin-B1
RBD
Surface charge and nonpolar regions mapped
onto the structure of the RBD (A and B) and ubiq-
uitin (C and D). View of (B) and (D) is the same as in
Figure 3.
For mutants T1795A (Figure 7C) and
T1802A (Figure 7D), both located in loop
L2, significant chemical shift changes
are apparent for residues close to the
site of the mutation, but also for several
residues in the long loop L3. The latter
perturbations are possible because this
loop, as well as part of L2, are flexible
(Bouguet-Bonnet and Buck, 2008). It is
likely that these regions are brought
together transiently by loop dynamics,
rather than by a subtle distortion of the
proteins’ core structure, as seen for the
mutations at L1815.
In order to model the structural pertur-
bations that may arise from the muta-
tions, we substituted the corresponding
side chains and used MD simulations.
State-of-the-art MD protocols were
used with the CHARMM/CMAP potential
function (see Experimental Procedures) in order to equilibrate
the change with the surrounding structure. Figure S2 shows
the two regions of interest, as the starting conformation and after
5 ns of simulation. Figure 8 presents results from a number of
analyses, either for an average of coordinate frames over the
last 2 ns of the trajectories (rmsd, accessibility) or as a function
of simulation time (dihedral angles, hydrogen bonding). In the
wild-type and all four mutant protein simulations, the core sec-
ondary structure appears to have reached a plateau with respect
to the rmsd from the starting main chain conformation. This is in
the range of 1.5–2.0 A˚ for the unmodified (wild-type) protein,
T1795A and T1802A, whereas L1815F and L1815P have an
rmsd from the starting structures of 2.0–3.0 A˚ (Figure 8A).
In the case of mutations T1795A and T1802A, structural and
dynamic changes are not easy to discern, as the region around
residues 1784–1804 is relatively dynamic. Similar to the chemical
shift perturbations, it is interesting to note that changes are local
by contrast to changes at position 1815, which appear to
Figure 5. Location of the Oncogenic Mutations and the Rho GTPase
Binding Region
Mutation sites are shown with side chains as ball-and-stick relative to the Rho
GTPase binding interface as determined by NMR (Tong et al., 2007). Two
plexin Rho GTPase association motifs (PRAMs), residues 1805–1817 and
1834–1841, colored green, are brought together by the tertiary fold.
Table 2. Binding Affinity of Plexin B1 and of Mutants with Rac1
in 50 mM Phosphate Buffer, pH 7.0, 4 mM MgCl2, 1 mM TCEP
Complex
Ka (M
-1) 3
105
Kd
(mM)
DH
kcal/mol
DG
kcal/mol
TDS
kcal/mol Tm
wtPlexin 1.63 6.1 12.1 7.1 5.0 49.0
Plexin W1830F 1.63 6.1 14.5 7.1 7.4 51.8
T1795A 1.92 5.2 14.6 7.2 7.4 52.1
T1802A 1.72 5.8 16.5 7.1 9.4 49.5
L1815F —a — — — — 52.0
L1815P — — — — — 43.1
a— indicates no change in heat/binding observed.
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The Plexin-B1 Rho GTPase Binding Domainpropagate to the region of L2, including to positions 1795 and
1802 (Figure 8B).
For the L1815P and L1815F mutants, a structural perturbation
is indicated in the two regions that surround the site of mutation,
located at the center of b strand 4. A little above this site, the short
a helix 2 (residues 1836–1839) shows increased deviation from
the starting structure of 2.6 A˚ and 3.0 A˚ at H1838 for L1815P
and L1815F, respectively, compared with an rmsd of 1.8 A˚ for
the wild-type protein (Figure 8C). The other neighboring region,
b strand 3, reveals the partial surface exposure of W1807 in the
case of L1815P (whereas this side chain is completely buried in
the wild-type protein) and, for R1808, the accessible surface
area is increased 120% for L1815F and 300% for L1815P. In
the case of L1815F, an overpacking of the region is themost likely
explanation for the change, whereas, for L1815P, it is associated
with an underpacking. Although the simulations are short, rms
fluctuations, averaged over the last 2 ns and plotted as a function
of sequence in Figure 8D, confirm that the L1815Fmutation leads
to increased fluctuations of helix a2, whereas no similarly dra-
Figure 6. Binding between Rho GTPases
and the Plexin-B1 RBD Detected by Isother-
mal Titration Calorimetry
Typical data for the Plexin-B1: Rac1 interaction
monitored by isothermal titration calorimetry in
phosphate buffer, pH 7.0, containing 4 mM
MgCl2 and 1 mM TCEP at 25
C. (Top) raw data;
(bottom) peak integrated enthalpy change; (A) for
plexin W1830F and (B) L1815P/W1830F.
Table 3. Free Energy of the Folded State of Plexin-B1
and of Cancer Mutants
Plexin-B1 DG (kcal/mol) DDGa m Mrel
b
wtPlexin 3.48 (0.21) — 3.72 (0.35) —
W1830F 3.49 (0.20) — 3.52 (0.17) —
T1795A 3.75 (0.28) 0.26 3.80 (0.24) 1.08
T1802A 4.34 (0.24) 0.85 3.37 (0.17) 0.95
L1815F 3.95 (0.21) 0.46 4.11 (0.19) 1.16
L1815P 1.20 (0.28) +2.29 2.97 (0.22) 0.84
T1795D 3.04 (0.22) +0.44 2.76 (0.23) 0.78
T1795E 7.41 (0.38) 3.92 4.42 (0.40) 1.25
T1802D 5.24 (0.28) 1.75 3.66 (0.19) 1.03
T1802E 4.28 (0.34) 0.79 3.19 (0.24) 0.90
aDDG = DGwt  DGmutant.
bMrel = relative m value with respect to wtPlexin.
matic change was observed in the main
chain in other regions or in other simula-
tions.
A major feature of the L1815Pmutation
is the lack of the P1815 amide group for
hydrogen bonding. Because one hydro-
gen bond to W1807 cannot be formed,
the b3–b4 strands are further apart at
this position throughout the simulation.
Transient excursions are seen in break-
ing the neighboring W1807 NH.P1815
O hydrogen bond, and, interestingly,
also for the W1807 O.F1815 NH hydro-
gen bond (Figures 8E and 8F). A modest change in side chain
packing is reflected in the altered average angle and increased
fluctuations of Y1839, especially in the L1815F mutant com-
pared with the wild type (Figure 8G). Although they are 6–8 A˚
apart, the aromatic rings of W1807 and Y1839 remain close to
parallel in all mutations (Figure 8H). In the case of the L1815F
mutant (Figure 9C), the Phe ring is inserted between the two
rings, also in a close-to-parallel orientation, suggesting that p-
ring stacking is a considerable influence on the orientation of
these side chains. Thus, overall, the data from the simulations
are consistent with the changes seen for these two mutants
by NMR spectroscopy, indicating that the region around residue
1815 has been altered in its structure and dynamics.
DISCUSSION
The topology of the 3D NMR solution structure of the Plexin-B1
RBD is that of a ubiquitin-fold, which is characterized by a five-
stranded b sheet and an a-helix that lies across the b sheet.
Also characteristic of the ubiquitin fold is a short helical or 310 he-
lical loop preceding the C-terminal b strand that is seen in the
plexin domain. The derived structure for the 120 residue protein
is in agreement with 1900 NOE restraints, supplemented by
58 dihedral angle and 36 hydrogen bond restraints. Although
the primary sequence homology with ubiquitin is low (15.7% se-
quence identity, 25.5% sequence similarity), several of the long-
range tertiary hydrogen bonding outside secondary structural el-
ements of the RBD are similar to those of the ubiquitin (Figure 2).
Subsequent to the NMR structure determination presented here,
a crystal structure of the same plexin-B1 domain has recently
been solved by the Structural Genomics Consortium at the Uni-
versity of Toronto and has also been deposited in the PDB
(PDB code: 2R2O). The crystallographic structure and NMR
structure are superimposable at 1.0 A˚ for themain chain second-
ary structural elements of the fold. A detailed comparison of the
two structures is beyond the scope of this report, and is not of
interest in the context of the study presented here.
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Y1746–L1853. A large part of this region is well conserved
among different members of the plexin family. For example, res-
idues D1775, Q1779, K1781, and K1783 in or close to helix a1
are conserved in all plexins known to date. We postulate that
the RBD of all the members of the plexin family will have a ubiq-
uitin-like domain similar to that of plexin-B1. Sequence conser-
vation at the protein surface and in loops can indicate regions
with similar functions. We used the ConSurf method to identify
such regions and map them onto the RBD structure (Figure 3)
(Armon et al., 2001). The conserved plexin-B1 RBD surface is
characterized by an elongated patch that runs alongside the
a helix to the helical turn, a2. This conserved surface suggests
a coupling between these two helical segments or possibly
a common binding interface. Other highly conserved residues
are P1793, T1795, and P1798, even though they are located in
a lengthy loop, L2, which has few contacts with the protein
core (see below). There is little similarity between the conserved
surface of the plexin RBD and the conserved surface regions of
ubiquitin. In the latter protein, several glycines, G10, G35, and
G47, are conserved, as is D52 (also located in a turn). The ubiq-
uitin protein is small but tightly packed in a complex topology,
making the location of certain residues critical.
The distribution of surface charges can also be used to suggest
protein regions that are functionally important. By contrast to the
patternsofconservation, severalsimilaritiesareapparent in thedis-
tributionof charge and hydrophobicity between the plexin-B1RBD
and human ubiquitin (Figure 4). The ‘‘front’’ side (helix on top of the
b sheet) of both the plexin-B1 RBD and ubiquitin are largely nega-
tively charged, whereas the ‘‘back’’ side of the molecules has
a sizeable, positively charged patch. The distribution of nonpolar/
hydrophobic patches also bears some similarity between the two
proteins. For example, on the back side of theRBD, a hydrophobic
ridge, comprised of T1846, S1809, V1811, and A1812, resembles
Figure 7. Chemical Shift Perturbation Due
to theMutationsMapped onto the Structure
Magenta, dD>0.25ppm;darkblue, dD>0.35ppm.
an uncharged area that also separates
regionswith positive and negative charges
(E18 and E64) in ubiquitin. A ridge com-
posed of residues P1851, V1850, and
A1848 (b5) with residues V1757, A1756,
and L1754 (b1) mimics a patch composed
of L8, L71, and L73 in ubiquitin. In the aver-
age NMR structure of the RBD, derived
from averaging of the 20 members of the
ensemble, the patch is significantly ob-
scuredby theconformationofahighly flex-
ible loop that joins b1 and b2, and there are
conformations that more readily expose
this hydrophobic region.
Kiel and Serrano have presented
a structural survey of the extended family
and initially concluded that the plexin
RBD was difficult to recognize as a ubiq-
uitin fold based on sequence homology
(Kiel and Serrano, 2006). However, a comparison of the struc-
tures reveals a close similarity to ubiquitin, rather than other
family members, suggesting, together with the surface charac-
teristics mentioned above, that the RBD could have a role similar
to ubiquitin’s function or interact with ubiquitin binding proteins.
Specifically, a hydrophobic patch in plexin-B1 resembles a patch
comprised of L8, L71, and L79 in ubiquitin (1UBQ), and the sec-
ond region, I44 and R42, used for binding of ubiquitin interacting
motifs, UIMs (Mueller et al., 2004), is similar to A1812 and H1814
in the RBD. To date, no interactions have been reported between
the plexin RBD and binding partners for ubiquitin or ubiquitin-like
domains. Nevertheless, it is tempting to speculate that the inser-
tion of a ubiquitin-like domain in the central cytoplasmic region of
a receptor may have a function in receptor transport or degrada-
tion. The finding that the RBD structure has not just a ubiquitin
fold, but also some of the features of ubiquitin, may stimulate fur-
ther experiments on the importance of the structure.
Conservation and amino acid physicochemical characteriza-
tion alone does not always reliably characterize binding inter-
faces. As an extension, several computational methods have
been developed that consider the relative solvent accessibility
of amino acids in the context of the protein’s fold. Such algo-
rithms appear to achieve a higher prediction accuracy. The
regions identified by one such recent program, SPPIDER (Porollo
and Meller, 2007) were considered for both ubiquitin and for the
plexin-B1 RBD (Figure S2). It is remarkable that ubiquitin’s inter-
face for binding partners is nearly correctly identified. In the case
of the RBD, the correspondence with the binding regions that are
suggested for ubiquitin is limited. In the RBD, the loop regions
and sides are extensively marked for putative interactions.
Although our knowledge of the binding interactions of the RBD
is still limited, we can discuss several of these predictions with
reference to ubiquitin-like folds and experimental data on Rho
GTPase binding to the plexin-B1 RBD.
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has several implications for plexin function. Ubiquin-like folds
are common domains in a wide range of proteins and have
diverse functions, ranging from their role in protein degrada-
tion, rescue, and transport to GTPase binding. Several Ras-
family small GTPases have been cocrystallized with ubiquitin-
like proteins, including the Ras-RalGDS (Huang et al., 1998)
and Rap-Raf complexes (Nassar et al., 1995). Binding to these
GTPases characteristically occurs through an interface com-
prised of b2, b1, and the C-terminal part of a1. Indeed, part
of this region is suggested as a putative binding site by the
SPPIDER predictions. Intriguingly, it was shown that plexin-
A1 as well as B1 binds to the active form of R-Ras when
Rnd1 is bound (Oinuma et al., 2004). However, using a variety
of methods, any attempt to detect binding of active R-Ras to
the RBD of plexin-B1 failed in our laboratory (even in presence
of Rnd1), confirming the suggestion that R-Ras interacts with
the Ras GAP (Negishi et al., 2005).
Remarkably, the SPPIDER predictions also highlight a region
on the opposite side of the molecule, comprised of b4, a2, and
loop3. A sequence located in a-2 has previously been associ-
ated with Rho GTPase binding (Hu et al., 2001; Tong et al.,
2005), and recently it has been possible to define b strand 4 as
a second region that is part of the binding surface (Tong et al.,
2007). It is intriguing that this region is brought into close contact
with residue L1815 by the tertiary structure of the ubiquitin fold,
suggesting that both the b4 and a2 structural elements are part
of the interaction surface with Rho GTPases, Rnd1 and Rac1.
Mutation of L1815 to proline or phenyalanine could, in principle,
dramatically alter the structure of the fold, but our CD, NMR, and
thermodynamic measurements show that the RBD fold is not
globally perturbed by any of the four oncogenic mutations. The
effect on RBD function is, therefore, likely to be more subtle,
but can still be rationalized on the basis of the RBD structure.
Mutations L1815P and L1815F
Residue L1815 is located at the center of strand b4 and is hydro-
gen bonded with both amide and carbonyl to residue W1807 in
b strand 3 (Figure 2A). Mutation to proline will abolish at least
one hydrogen bond (Figures 8E and 8F) and significantly destabi-
lizes the fold of the domain. In addition, the leucine side chain
forms one side of a hydrophobic cluster, surrounded by the
side chains of L1817, V1805, and W1807, and points toward
Y1839 (Figure 9B). On mutation to Pro, removal of the Leu side
chain results in a significant loss of van der Waals and hydropho-
bic contacts. Replacement of Leuwith Phe, whilemaintaining the
hydrophobic character of the side chain, slightly overpacks this
region (Figures 8C and 8D). However, proteins are typically plas-
tic enough to tolerate such a change, and thus no significant
change in the overall stability of the domain is observed for the
latter mutant. This lack of a change in protein stability could arise
due to a compensatory effect. Clashes in one region that desta-
bilize the interaction of the two b strands 3 and 4 are attenuated
by additional stability that is obtained through a stacking of
aromatic rings in the case of the L1815F mutant. Such p-p inter-
actions are frequent in proteins (McGaughey et al., 1998), and the
MD modeling shows that Y1839, F1815, and W1807 are placed
into an energetically favorable arrangement that could be difficult
to break on binding of GTPase to this region. Thus, both L1815PStructure 16,and L1815F mutant lose affinity toward Rac1 and Rnd1, but for
different reasons. The structure suggests that desolvation/lack
of contacts and resistance to a conformational change at this
site, respectively, will be important determinants for complex for-
mation with Rho GTPases.
Mutations T1795A and T1802A
Both residues are relatively distant from the interaction surface
with Rho GTPases, and no significant change in binding affinity
is seen. Also, there is no significant change in global stability of
the domain. Both residues are located in a moderately flexible
region of the domain, as judged by rmsd in the NMR ensemble
and N-H order parameters (Bouguet-Bonnet and Buck, 2008).
As shown in Figure 5, T1795A is located near the center of
a long loop connecting a1 with b3, and T1802 is toward the
C terminus of this loop, close, but not in contact with, b3 and
the C terminus of strand b1. Both side chains are exposed at
the protein surface; thus, any structural and thermodynamic/
dynamic changes are likely to be limited, and do not provide a ra-
tionale for the putative effect of these mutations on the signaling
mechanism of plexin. It is interesting that both mutations are to
Ala and occur in regions that have a turn-like structure. MDmod-
eling shows an increased tendency in this region for transient for-
mation of a-helical turns in bothmutants. Alternatively, either one
or both of these side chains could be involved in Ser/Thr phos-
phorylation (Wong et al., 2007), causing a conformational change
in theRBDdomain and/or interactionwith an adaptor protein that
recognizes the phosphorylated side chain. At this point, neither
the kinase that would phosphorylate the sites nor putative inter-
action partners are known. Thus, this implication remains specu-
lative, but may stimulate further investigation. We examined the
possibility that a conformational change is caused by Thr phos-
phorylation using phospho-mimicking mutations (to Asp or to
Glu) at both sites. However, theGTPase binding affinity and over-
all thermodynamic stability of these variants is not affected (Table
3). The chemical shifts are perturbed only locally, suggesting that
no significant change in protein conformation would take place
upon a putative phosphorylation event. A phosphorylation of ei-
ther or both T1975/1902 could, nevertheless, be used for recog-
nition purposes, and mutation of the sites to Ala is likely to inter-
fere with a binding event.
It is interesting to note that the flexibility of the loop connecting
a1with b3 is significantly reduced as a result of salt bridges, such
as between the side chains of D1786 and R1797 and R1801 with
D1819/E1820 or D1799.Mutation of either T1795 or T1802, close
to these sides, may alter the loop preferences (see preceding
paragraph) and change, if not disrupt, these interactions. A sec-
ond cause for reduced loop flexibility are three proline residues,
P1793, P1798, and P1800, two of which (1793 and 1798) are
absolutely conserved in all vertebrate plexins except for plexin-
C1. The two oncogenic Thr to Ala mutations follow two of these
prolines, with the entire region presenting a PxTxxPxPxT motif.
Similar types of motifs are used for the binding of SH3-type
adaptor proteins and it is, therefore, likely that the oncogenic
mutations would disrupt such an interaction.
Finally, the structure of the RBD has implications for the role of
the RBD in the signaling mechanism of plexins. The RBD has
been classified as an effector domain for certain Rho GTPases
(Vikis et al., 2000; Driessens et al., 2001). This type of cell246–258, February 2008 ª2008 Elsevier Ltd All rights reserved 253
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The Plexin-B1 Rho GTPase Binding Domainsignaling protein typically functions by undergoing significant
conformational changes in response to the binding of signal in-
putmolecules. Often, these transitions are accompanied by fold-
ing/unfolding events, and are indicated by changes in the ther-
modynamic stability of the global protein fold. While mutation
L1815P significantly destabilizes the RBD fold and is accompa-
nied by a dramatic loss of binding affinity, the stability of the do-
main is essentially unchanged for the L1815F mutant. However,
this mutant also lacks binding affinity. Similarly, no general cor-
relation appears to exist between apparent oncogenesis,
GTPase binding, and domain stability in the case of the
T1795A and T1802A mutants. As seen above, changes in local
conformational stability, physicochemical character of the bind-
ing interface, and its dynamics are likely to play key roles. In the
case of the T1795A and T1802A mutations, other mechanisms
beyond the RBDdomain itself will influence plexin’s signaling be-
havior. However, the observation that the RBD fold is relatively
unstable, with a free energy of folding of 3.5 kcal/mol at 15C,
pH 6.8, is striking, and suggests that global conformational
changes of the domain are part of the signalingmechanism. Spe-
cifically, the N-terminal region of the RBD is very close to the end
of the first GAP homologous domain, and it is possible that the
two are in contact or partially overlap, providing a mechanism
by which Rho GTPase binding may be communicated to the
GAP domains. In addition, it is known that the GTPase binding
affinity of the RBD can be significantly attenuated by the sur-
rounding GAP domains (Puschel, 2007), also implying that inter-
domain contacts play a considerable role. Thus, the structure of
Figure 8. Molecular Dynamics Analysis of the Plexin-B1 RBD
MD analyses of mutants T1795A (green), T1802A (magenta), L1815P (blue), L1815F (red) compared to the wild-type protein (black).
(A) Main chain rmsd of the protein secondary structure from the starting conformation as a function of simulation time.
(B and C) Same rmsd, but on a residue basis for (B) loop L2 and (C) helix a2.
(D) Main chain rms fluctuation over the last 2 ns for residues in helix a2.
(E and F) Distances between main chain nitrogen/oxygen atoms of residues 1815 and 1807. A window averaging of 100 ps was used.
(G) c1 angle of Y1839.
(H) Angle between ring planes Y1839.W1807.
Figure 9. Conformational Changes in
L1815F and L1815P Mutants
(A) Two regions of interest are shown, with the
positions of certain side-chains superimposed on
the main chain conformation. (B) Binding site for
Rho GTPases viewed from a different angle (as
seen from the back of the structure in [A]). Snap-
shots of the structure of models after 5 ns of MD
at 300K. Region around residue 1815: (C) wild
type; (D) L1815F; (E) L1815P.
the isolated RBD domain reported here
may represent only part of one state of
the conformational states of the cytoplas-
mic region of the plexin receptor.
A structural and thermodynamic study
of the plexin-B1 RBD has revealed sev-
eral features that are typical of ubiquitin-
like folds. Surprisingly the protein domain
is characterized by a relatively low ther-
modynamic stability. A perturbation to the region associated
with Rho GTPase binding by oncogenic mutations, L1815P
and L1815F, result in a dramatic loss of binding affinity toward
active Rac1 and Rnd1 GTPases. MD modeling and NMR sug-
gest that both mutants perturb the interaction site. By contrast,
mutations T1795A and T1802A have subtle structural and
dynamic effects that are confined to the surrounding residues,
and are likely to show altered affinity to as yet unidentified adap-
tor proteins that bind to proline or to phosphorylated threonine
groups. Future experiments will be needed to test these possibil-
ities, also in the context of the GTPase activating homologous
domains that surround the RBD.
EXPERIMENTAL PROCEDURES
Protein Overexpression and Purification
Construction of the gene encoding plexin-B1 RBD, W1830F, overexpression
and purification of the protein has been described previously (Tong et al.,
2005). Specifically, a 15N, 13C, 2H-labeled, Val, Leu, Ile (d1) methyl-protonated
sample was prepared following the protocol of Goto et al. (1999). The sample
buffer for NMR experiments contained 50mMNaCl, 4mMMgCl2, 4mMDTT in
50mMphosphate buffer (pH 6.8), 90%H2O/10%D2O, unless otherwise spec-
ified. Protein concentration was 1.0–2.0 mM. QuickChange site-directed mu-
tagensis kit (Stratagene) was used to make point mutations in the RBD, and
proteins were purified as above. The constitutively active Rac1 construct
used encodes residues 1–184 and mutations Q61L and C178S. A truncated
Rnd1 construct encoding residues 5–200 was obtained from Structure Geno-
mics Consortium, Oxford, and the protein was purified as previously described
(http://thesgc.com/SGC-WebPages/StructureDescription/2CLS.php).
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NMRexperimentswere carried out at 298K on either a Bruker Avance 600MHz
spectrometer equipped with a cryoprobe or a Varian Inova 600 MHz. A simul-
taneous edited 15N/13C-HSQC-NOESY (mixing time, 100 ms) (Sattler et al.,
1995) was acquired on a 15N, 13C doubly labeled sample. A 3D 13C-edited
HMQC-NOESY (mixing time, 150 ms) and a 3D version of 15N-HSQC-NOE-
SY-15N-HSQC (t1, t2, t3 =
15N, 15N, 1H; mixing time, 150 ms) were acquired
on a methyl-protonated 15N, 13C, 2H triple-labeled sample. Hydrogen bond
experiments were acquired by Helena Kovacs on a Bruker Avance 600MHz
spectrometer with cryoprobe (Kovacs et al., 2005). All data were processed
with nmrPipe and analyzed with NMRView. Assignment of chemical shifts
was reported previously (Tong and Buck, 2005).
Cyana 2.1 (Guntert, 2004) was used for structure calculation. TALOS (Corni-
lescu et al., 1999) in the nmrPipe package was used to derive a total of 116 f
and c angular constraints from the backbone chemical shifts. Eighteen exper-
imentally determined hydrogen bonds were used as 36 upper/lower limit dis-
tance restraints between the donor protons/parent atoms and the acceptor
atoms. Partially assigned, integrated NMRView peaklists were fed into the
NOEASSIGN module together with the dihedral constraints and hydrogen
bond constraints. The automatic assignment/calculation module generated
100 initial structures and used 10,000 torsion angle dynamics steps for 7
rounds of iterative assignment and calculation. The final output constraints
from this procedure, upper limit constraints, and stereo-specific assignments
were combined with the dihedral restraints and hydrogen bonds for a final
round of structure calculation. Ten different numbers were then selected as
random seed, each used to generate 20 initial structures for the CYANA calcu-
lation. The 20 structures with the lowest energy from the total of 200 structures
were selected to represent this structural ensemble. A total of 30,000 torsion
angle dynamics steps were used for the final structure calculation. Water
refinement of plexin-B1 RBD after Cyana calculation used Xplor-NIH and
followed the refinement script of Nederveen et al. (2005) with one slight mod-
ification. A 10 A˚ shell of explicitly represented waters was used for the simu-
lated annealing, but all except the 4.5 A˚ closest waters (heavy atom distance)
were deleted prior to the final minimization. The ensemble of 20 structures was
analyzed with the Protein Structure Validation Suite, PSVS (Laskowski et al.,
1996). The coordinates of the human plexin-B1 RBD (residues 1743–1862)
W1830F have been deposited in the Protein Data Bank (PDB code: 2JPH). Fig-
ures of the protein coordinates were generated using MolMol (Koradi et al.,
1996) or PyMol (DeLano Scientific, Palo Alto, CA, USA. http://www.pymol.org).
Structural Analyses
Following superposition on the secondary structural elements, the nonmini-
mized geometric average structure of 20 ensemble members was used for
all analysis. The results with individual members are very similar. The following
programs were used with default parameters: ConSurf (Armon et al., 2001),
MolMol (Koradi et al., 1996) to calculate charged surfaces, and SPPIDER
(Porollo and Meller, 2007).
MD Calculations
The program NAMD (version 2.6) was used to set up five MD simulations,
whichwere run for 5 ns to study thewild-type and the fourmutants of the plexin
RBD. Prior to the production run, the mutants were built by using the IC facility
in CHARMM (version c32a2), followed by a brief minimization to remove
clashes. In all simulations, the CHARMM22/CMAP force field was used. In
each case, the RBD was first immersed in a cubic box of water with a side
length of 70 A˚, and periodic boundary conditions were applied. Each system
was neutralized by adding two chloride ions, and all solvent molecules with
distances from heavy protein atoms less than 2.8 A˚ were deleted, resulting in
more than 10,000 water molecules. The systems were then minimized, heated
up, and equilibrated. The production stages of simulations were performed in
NPT ensemble at a temperature of 300K and a pressure of 1.0 atm.
The temperature was kept constant with a Brendsen thermostat, and
the Langevin Piston method was employed to control the pressure. A 12 A˚
cutoff was used for the calculation of the nonbonded interactions, and
the long-range electrostatic forces were computed by the particle-mesh
Ewald method. All bonds involving hydrogen atoms were kept rigid with the
SHAKEalgorithm,anda timestepof 2 fswasused. Thecoordinateswere saved
every 2 ps.256 Structure 16, 246–258, February 2008 ª2008 Elsevier Ltd All riCalorimetry
Interaction studies of Plexin-B1 and Rac1/Rnd1 were carried out with an
isothermal titration calorimeter (VP-ITC; MicroCal, Inc.). Both the proteins
were exchanged with the same buffer prior to the experiment. The primary
ligand (Rac1/Rnd1) was placed into a sensitive temperature-controlled cell
(volume, 1.43 ml), and the secondary ligand (plexin-B1) was placed into a
syringe immersed into the cell (capacity, 0.295 ml). The concentration of
Rac1/Rnd1 was 40 mM, and the concentration of plexin-B1 was set to 15-
fold higher than that for Rac1/Rnd1 (at 600 mM). The data were analyzed
with MicroCal’s Origin software, which give the stoichiometry (N), binary equi-
librium binding constant (Ka, which is equal to [GTPase.Plexin] / [GTPase] 3
[Plexin]), and enthalpy of binding (DH). Protein stability with respect to temper-
ature was determined with a differential scanning calorimeter (VP-DSC; Micro-
Cal, Inc.) over a range of temperatures (10C–100C). Protein solution should
be 40 mM–600 mM for GTPase-RBD interaction and 2 mM for RBD dimeriza-
tion. A total of 4 mMDTTwas replaced with 1.0 mM TCEP in all calorimetry ex-
periments. Data were analyzed with theOrigin programwith a two statemodel.
CD
CD spectra were recorded on an AVIV Model 215 CD instrument, in the far-UV
region (190–250 nm), with a band width of 1 nm, slit width of 1 mm, and with
a cuvette of 10 mm path length. Spectra were baseline corrected against sol-
vent. Free energy of the native state for plexin-B1 and its mutants at 15Cwere
determined by measuring mean residue of ellipticity [qm] (degrees cm
2 dec-
imole1) with equation, [qm] = q / (10C 3 n 3 l), where q is observed ellipticity
inmillidegreesatwavelength222nm,C isprotein concentration (mol/l), n isnum-
ber of amino acids per protein molecule (i.e., 120), l is path length (i.e., 10 mm).
The data obtained were fitted to the following equation, described elsewhere
(Padmanabhan et al., 1999), and analyzed in Origin software. The ellipticity
was then followed with respect to the titration with guanidine HCl.
Y= ðen +mn$x+ ðeu +mu$xÞ3 ðexpð  ðDG+m$xÞ=RTÞÞÞ=
ð1+ expð  ðDG+m$xÞ=RTÞÞ;
where RT = 0.592 kcal/mol and DG = free energy change in the absence of
denaturant.
Supplemental Data
Supplemental Data include two figures and are available with this article online
at http://www.structure.org/cgi/content/full/16/2/246/DC1/.
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